Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
Karuna Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Karuna Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, five executives at Karuna Therapeutics received on average a compensation package of $5.7M, a 9% increase compared to previous year.
Average pay of disclosed executives at Karuna Therapeutics
Steven Paul, Chief Executive Officer, received $13M in total, which increased by 48% compared to 2020. 91% of Paul's compensation, or $12M, was in option awards. Paul also received $550K in non-equity incentive plan, $645K in salary, as well as $8.7K in other compensation.
Andrew Miller, Chief Operating Officer, received a compensation package of $5.7M, which increased by 23% compared to previous year. 86% of the compensation package, or $4.9M, was in option awards.
Stephen Brannan, Chief Medical Officer, earned $4.5M in 2021, a 30% increase compared to previous year.
Troy Ignelzi, Chief Financial Officer, received $4.5M in 2021, which increases by 20% compared to 2020.
Charmaine Lykins, Chief Commercial Officer, earned $488K in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2022.